Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuel Monreal

Showing results (261-270 of 451) with videos related to

Pageof 46
Sort By:
Thrombosis Journal|October 27, 2015
The management of acute venous thromboembolism in clinical practice - study rationale and protocol of the European PREFER in VTE RegistryGiancarlo Agnelli, Anselm K Gitt, Rupert Bauersachs, et al.
Thrombosis and Haemostasis|April 15, 2020
Psychotropic Drugs and Outcome in Patients Receiving Anticoagulant Therapy for Venous ThromboembolismPablo Javier Marchena, Inna Tzoran, Benjamin Brenner, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|June 29, 2019
Outcomes beyond the Third Month of Anticoagulation in Patients Aged >75 Years with a First Episode of Unprovoked Venous ThromboembolismAmaia Iñurrieta, José María Pedrajas, Manuel Jesús Núñez, et al.
Thrombosis Research|January 6, 2020
Recent trends in use of inferior vena caval filters in US older adults with acute pulmonary embolismBehnood Bikdeli, Yun Wang, David Jimenez, et al.
Thrombosis and Haemostasis|May 19, 2025
Geographic and Racial Variation in Outcomes of Acute Venous Thromboembolism: Insights from the RIETE RegistryAlfonso Tafur, Benjamin Brenner, Pablo Demelo-Rodriguez, et al.
Thrombosis and Haemostasis|October 3, 2013
Impact of age on the efficacy and safety of extended-duration thromboprophylaxis in medical patients. Subgroup analysis from the EXCLAIM randomised trialRoger D Yusen, Russell D Hull, Sebastian M Schellong, et al.
Medicine|December 4, 2015
Platelet Count and Major Bleeding in Patients Receiving Vitamin K Antagonists for Acute Venous Thromboembolism, Findings From Real World Clinical PracticeMatteo Giorgi-Pierfranceschi, Pierpaolo Di Micco, Chiara Cattabiani, et al.
British Journal of Haematology|June 2, 2021
Risk of recurrent venous thromboembolism in patients with autoimmune diseases: data from the Registro Informatizado de Enfermedad TromboEmbólica (RIETE) registryJaime Borjas Howard, Pablo Ruiz-Sada, Karina de Leeuw, et al.
Thrombosis Research|June 19, 2021
Difference between Japanese and White patients with acute pulmonary embolismYugo Yamashita, Behnood Bikdeli, Manuel Monreal, et al.
International Journal of Cardiology|February 23, 2021
Refinement of a modified simplified Pulmonary Embolism Severity Index for elderly patients with acute pulmonary embolismRaquel Morillo, David Jiménez, Behnood Bikdeli, et al.
Pageof 46

Showing results (261-270 of 451) with videos related to

Sort By:
Pageof 46
Thrombosis Journal|October 27, 2015
The management of acute venous thromboembolism in clinical practice - study rationale and protocol of the European PREFER in VTE RegistryGiancarlo Agnelli, Anselm K Gitt, Rupert Bauersachs, et al.
Thrombosis and Haemostasis|April 15, 2020
Psychotropic Drugs and Outcome in Patients Receiving Anticoagulant Therapy for Venous ThromboembolismPablo Javier Marchena, Inna Tzoran, Benjamin Brenner, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|June 29, 2019
Outcomes beyond the Third Month of Anticoagulation in Patients Aged >75 Years with a First Episode of Unprovoked Venous ThromboembolismAmaia Iñurrieta, José María Pedrajas, Manuel Jesús Núñez, et al.
Thrombosis Research|January 6, 2020
Recent trends in use of inferior vena caval filters in US older adults with acute pulmonary embolismBehnood Bikdeli, Yun Wang, David Jimenez, et al.
Thrombosis and Haemostasis|May 19, 2025
Geographic and Racial Variation in Outcomes of Acute Venous Thromboembolism: Insights from the RIETE RegistryAlfonso Tafur, Benjamin Brenner, Pablo Demelo-Rodriguez, et al.
Thrombosis and Haemostasis|October 3, 2013
Impact of age on the efficacy and safety of extended-duration thromboprophylaxis in medical patients. Subgroup analysis from the EXCLAIM randomised trialRoger D Yusen, Russell D Hull, Sebastian M Schellong, et al.
Medicine|December 4, 2015
Platelet Count and Major Bleeding in Patients Receiving Vitamin K Antagonists for Acute Venous Thromboembolism, Findings From Real World Clinical PracticeMatteo Giorgi-Pierfranceschi, Pierpaolo Di Micco, Chiara Cattabiani, et al.
British Journal of Haematology|June 2, 2021
Risk of recurrent venous thromboembolism in patients with autoimmune diseases: data from the Registro Informatizado de Enfermedad TromboEmbólica (RIETE) registryJaime Borjas Howard, Pablo Ruiz-Sada, Karina de Leeuw, et al.
Thrombosis Research|June 19, 2021
Difference between Japanese and White patients with acute pulmonary embolismYugo Yamashita, Behnood Bikdeli, Manuel Monreal, et al.
International Journal of Cardiology|February 23, 2021
Refinement of a modified simplified Pulmonary Embolism Severity Index for elderly patients with acute pulmonary embolismRaquel Morillo, David Jiménez, Behnood Bikdeli, et al.
Pageof 46